IP Library Granted Patent US 10,022,472
Granted Patent B2
US 10,022,472 · App. 15/192,368 · Granted Jul 17, 2018

Connective-tissue-based or dermal-tissue-based grafts/implants

Inventors: C. Randal Mills (Tioga, FL); John R. Bianchi (Gainesville, FL); Michael R. Roberts (Gainesville, FL); David T. Cheung (Arcadia, CA); Chandrasekaran Nataraj (Gainesville, FL); John W. Howell, Jr. (Gainesville, FL)
Assignee: RTI Surgical, Inc.
A61L27/3608A61F2/08A61F2/105A61L27/3604A61L27/3687A61L27/3691A61L27/38A61L27/3826A61L27/46A61L27/54A61L27/56A61F2002/0894A61L2300/414A61L2400/06A61L2430/02A61L2430/10A61L2430/30B33Y80/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,022,472
App. No.
15/192,368
Granted
Jul 17, 2018
Kind
B2
Abstract

The present invention is directed to a composition comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. Also disclosed is a tissue graft or implant comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. The composition and/or tissue graft or implant of the invention is usable in combination with seeded cells, a tissue growth factor, and/or a chemotactic gent to attract a desired cell.

Claims (23)

1. A dermal scaffold implant comprising

a matrix of allogeneic or xenogenic tissue wherein said matrix is formed from a processed dermal tissue slurry and said matrix is dried to a shape selected from the group consisting of a disk, a strip, a sheet, a molded 3D shaped object, a sponge, and a gasket; and

wherein said implant has the property of holding said shape during rehydration and handling.

2. The implant of claim 1 wherein said shape is a molded 3D shape to fit an anatomical feature or surgically created space.

3. The implant of claim 1 , wherein the implant further comprises seeded cells, a growth factor, a chemotactic agent, or a combination thereof.

4. The implant of claim 3 , wherein the implant comprises a growth factor for inducing the growth of fibroblasts, melanocytes, osteogenic cells, stem cells, skin cells or a combination thereof.

5. The implant of claim 3 , wherein said implant comprises seeded cells that are fibroblasts, melanocytes, osteogenic cells, stem cells, skin cells or a combination thereof.

6. The implant of claim 1 , which has a moisture content of 3% or less.

7. The implant of claim 1 , wherein said shape is a strip.

8. The implant of claim 7 , wherein said strip has dimensions of about 10 mm to 500 mm long, by about 10 mm to 200 mm wide and about 1 mm to 10 mm thick.

9. The implant of claim 7 , wherein said strip has dimensions of about 50 mm to 90 mm long by about 15 mm to 35 mm wide and about 2 mm to 5 mm thick.

10. The implant of claim 7 , wherein said strip has a cross section of a rectangle, square, triangle, polygon, circle, half circle, ellipse, or partial ellipse.

11. The implant of claim 1 , wherein said shape is a disk.

12. The implant of claim 11 , wherein said disk has dimensions of about 10 mm to 100 mm diameter and about 1 mm to 10 mm thick.

13. The implant of claim 1 , wherein said shape is a molded 3D shape.

14. The implant of claim 13 , wherein said molded 3D shape has dimensions of about 100 mm by about 100 mm and about 25 mm thick.

15. The implant of claim 13 , wherein said molded 3D shape has dimensions of about 50 mm by about 70 mm and about 20 mm thick.

16. The implant of claim 13 , wherein said molded 3D shape has dimensions of about 30 mm by about 50 mm and about 15 mm thick.

17. The implant of claim 1 , wherein said shape is a sheet.

18. The implant of claim 13 , wherein said sheet has dimensions of about 100 mm by about 100 mm and about 25 mm thick.

19. The implant of claim 13 , wherein said sheet has dimensions of about 20 mm to 300 mm by about 10 mm to 100 mm and about 1 mm to 10 mm thick.

20. The implant of claim 1 , wherein said implant is packaged and sterilized.

21. The implant of claim 1 , wherein said implant is rehydrated prior to use by contacting with water, saline, blood, plasma, a buffered solution, or another liquid.

Assignments (15)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Sep 25, 2025
From: ARES CAPITAL CORPORATION
To: RTI SURGICAL INC. D/B/A EVERGEN
Reel/Frame 072938/0203 →
RELEASE OF SECURITY INTEREST Recorded Jul 21, 2020
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
Reel/Frame 053260/0398 →
RELEASE OF SECURITY INTEREST Recorded Jul 20, 2020
From: ARES CAPITAL CORPORATION, AS AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
Reel/Frame 053257/0652 →
CHANGE OF NAME Recorded Jul 20, 2020
From: RTI OEM, LLC
To: RTI SURGICAL, INC.
Reel/Frame 053259/0146 →
CHANGE OF NAME Recorded Jul 20, 2020
From: RTI SURGICAL, INC.
To: SURGALIGN SPINE TECHNOLOGIES, INC.
Reel/Frame 053248/0432 →
INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT Recorded Jul 20, 2020
From: SURGALIGN SPINE TECHNOLOGIES, INC. (FORMERLY KNOWN AS RTI SURGICAL, INC.)
To: RTI OEM, LLC
Reel/Frame 053259/0019 →
SECURITY INTEREST Recorded Mar 8, 2019
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 048543/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2018
From: MILLS, C. RANDAL; BIANCHI, JOHN R.; ROBERTS, MICHAEL R.; CHEUNG, DAVID T.; NATARAJ, CHANDRASEKARAN; HOWELL, JOHN W., JR.
To: REGENERATION TECHNOLOGIES, INC.
Reel/Frame 046410/0374 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2018
From: TD BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.
Reel/Frame 046327/0864 →
SECURITY INTEREST Recorded Jun 6, 2018
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS THE ADMINISTRATIVE AGENT
Reel/Frame 046303/0926 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2018
From: MILLS, C. RANDAL; BIANCHI, JOHN R; ROBERTS, MICHAEL R; CHEUNG, DAVID T; NATARAJ, CHANDRASEKARAN; HOWELL, JOHN W, JR.
To: REGENERATION TECHNOLOGIES, INC.
Reel/Frame 045038/0183 →
MERGER Recorded Feb 26, 2018
From: REGENERATION TECHNOLOGIES, INC.
To: REGENERATION TECHNOLOGIES, INC.
Reel/Frame 045038/0275 →
MERGER Recorded Feb 26, 2018
From: RTI BIOLOGICS, INC.
To: RTI SURGICAL, INC.
Reel/Frame 045441/0310 →
MERGER Recorded Feb 26, 2018
From: REGENERATION TECHNOLOGIES, INC.
To: RTI BIOLOGICS, INC.
Reel/Frame 045441/0347 →
SECURITY INTEREST Recorded Aug 20, 2017
From: RTI SURGICAL, INC.
To: TD BANK, N.A.
Reel/Frame 043608/0874 →
Continuity (8)
Continuation 14284918 · May 22, 2014
Continuation 13815184 · Feb 7, 2013
Continuation 12807599 · Sep 9, 2010
Continuation 11949687 · Dec 3, 2007
Continuation 11480711 · Jul 3, 2006
Continuation 10793976 · Mar 5, 2004
Continuation In Part 10754310 · Jan 9, 2004
Related Publication 20160317708A1 · Nov 3, 2016
Cited By (2)
US 12,447,180 US 12,629,453